Skip to main content

Table 3 Known genes effects on ferroptosis in various cancers

From: Novel insights on targeting ferroptosis in cancer therapy

Tumor type

Gene

Effect

References

Mechanism

Lymphoma

GPX4

Inhibition

Yang, W.S et al. [35]

Reduce the accumulation of ROS

 

CHAC1

Promotion

Wang et al. [65]

Degrade GSH

HCC

NRF2

Inhibition

Sun, X et al. [67]

Encode antioxidant proteins

 

HIC1

Promotion

Xiao Zhang et al. [68]

Affect the synthesis of GSH

 

HNF4A

Inhibition

  
 

CISD1

Inhibition

Yuan, H et al. [69]

Suppress mitochondrial lipid peroxidation

 

GABPB1-AS1

Promotion

Qi, W et al. [70]

Inhibited the cellular antioxidant capacity

RCC

GPX4

Inhibition

Yang et al. [35]

Reduce the accumulation of ROS

 

TAZ/NOX

Promotion

Yang et al. [71]

Exhaust intracellular NADPH

 

BAP1

Inhibition

Zhang, Y et al. [14]

Decreases SLC7A11 expression

Ovarian cancer

TFR1

Promotion

Pizzamiglio et al. [72]

Increase the intake of iron

 

TAZ/NOX

Inhibition

Yang et al. [73]

Reduce the depletion of NADPH

Pancreatic cancer

HSPA5

Inhibition

Zhu, S et al. [74]

Inhibit the expression of TFR1

 

SystemXc−

Inhibition

Lo M et al. [75]

Increase the synthesis of GSH

 

GRP78

Inhibition

Wang, K et al. [76]

Unkown

Breast cancer

TFR1

Promotion

Basuli et al. [77]

Increase the intake of iron

 

CHAC1

Promotion

Chen et al. [78]

Degrade GSH

 

ACSL4

Promotion

Doll, S et al. [79]

Increasing cellular lipid composition

 

P53RRA

Promotion

Chao Mao et al. [80]

Nuclear sequestration of p53

Head and neck cancer

NRF2

Inhibition

Sun, X et al. [81]

Encode antioxidant proteins

Colorectal cancer

P53

Inhibition

Xie Y et al. [82]

Increase the expression of systemXc−

Cervical carcinoma

Melanoma

HSPB1

SLC1A5

GOT1

Inhibition

Promotion

Inhibition

Stuart et al. [62] Sun, X et al. [29]

Luo, M et al. [83]

Zhang, K et al. [84]

Inhibit the expression of TFR1

Reduce the accumulation of Glu

Decrease the depletion of Glu